Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research and Development of New Strategies for the Early Detection and Prevention of Gastric Cancer in the Spanish Population: EpiGASTRIC/EDGAR Project.

NCT05551416 is registered in ClinicalTrials.gov with EDUARDO ALBENIZ as lead sponsor.

NCT NCT05551416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research and Development of New Strategies for the Early Detection and Prevention of Gastric Cancer in the Spanish Population: EpiGASTRIC/EDGAR Project.
Lead sponsor
EDUARDO ALBENIZ
Phase
Observational
Overall status
Recruiting
Start date
September 9, 2021
Completion date
December 31, 2026
Enrollment
1,200 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastric lesion, gastric neoplasms